Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464638013 | Glyburide 1.25mg/metformin 250mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2470998018 | Glyburide 1.25mg/metformin 250mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3486705015 | Product containing glibenclamide 1.25 mg and metformin 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493206010 | Product containing glyburide 1.25 mg and metformin 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493207018 | Product containing glibenclamide 1.25 mg and metformin 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501896013 | Glibenclamide 1.25 mg and metformin 250 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501897016 | Glyburide 1.25 mg and metformin 250 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569870018 | Product containing only glibenclamide 1.25 mg and metformin 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569871019 | Product containing only glyburide 1.25 mg and metformin 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569872014 | Product containing only glibenclamide 1.25 mg and metformin 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3679277013 | Glyburide 1.25 mg and metformin hydrochloride 250 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3679278015 | Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3679279011 | Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3679280014 | Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 105051001000001110 | Glyburide 1.25mg/metformin 250mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | Product containing glibenclamide and metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has active ingredient | Glyburide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has active ingredient | Glibenclamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | Product containing metformin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Glibenclamide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 1.25 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has active ingredient | Glibenclamide | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Glibenclamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 1.25 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Glibenclamide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | Product containing glibenclamide and metformin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | Product containing only glibenclamide and metformin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Glibenclamide | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR